Key result
Chylopericardium carries high surgical burden, presenting with tamponade in ~38% of cases.
Systematic Review (n=98)
Answers are grounded in this paper and cite their sources.
OBJECTIVE: Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteristics, management and outcomes. METHODS: We performed a literature search and identified cases of patients with CPE from 1946 until May 2021 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We identified relevant articles for pooled analyses of clinical, diagnostic and outcome data. RESULTS: A total of 95 articles with 98 patients were identified. Patient demographics demonstrated male predominance (55%), with a mean age of 37±15 years. Time from symptom onset to diagnosis was 5 (Q1 4.5, Q3 14) days, with 74% of patients symptomatic on presentation. Idiopathic CPE (60%) was the most common aetiology. Cardiac tamponade secondary to CPE was seen in 38% of cases. Pericardial fluid analysis was required in 94% of cases. Lymphangiography identified the leakage site in 59% of patients. Medical therapy (total parenteral nutrition, medium-chain triglycerides or octreotide) was undertaken in 63% of cases. In our cohort, 32% progressed towards surgical intervention. During a median follow-up of 180 (Q1 180, Q3 377) days, CPE recurred in 16% of cases. Of the patients with recurrence, 10% were rehospitalised. CONCLUSION: CPE tends to develop in younger patients and may cause serious complications. Many patients fail medical therapy, thereby requiring surgical intervention. Although overall mortality is low, associated morbidities warrant close follow-up and possible reintervention and hospitalisations.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2023) conducted a systematic review in Chylopericardium (n=98). Medical therapy (total parenteral nutrition, medium-chain triglycerides, or octreotide) and surgical intervention was evaluated on Recurrence of chylopericardium and progression to surgical intervention. Chylopericardium presented with cardiac tamponade in 38% of cases, required surgery in 32% after 63% received medical therapy, and recurred in 16% over a median 180-day follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: